Big Pharma cash taints policy, politics, patient advocacy: Silvestrini

news

(Photo: TNS)Big Pharma money seems to be seems everywhere anyone is making policy or taking any kind of action involving drug manufacturers.
But the details of how much Pharma money has influenced and potentially tainted policy making, medical education and even patient advocacy are sobering.
Consider:• Doctors who write prescriptions and researchers who investigate drugs have been paid billions by drug companies, according to the government’s Open Payments database.
The FDA depends heavily on funding from the industry and is required to work closely with drug manufacturers in developing regulations and procedures.
Patient advocacy groups may be the most troubling benefactors of all that pharma money.
Source: Big Pharma cash taints policy, politics, patient advocacy: Silvestrini